brand logo

Am Fam Physician. 2018;97(1):8

Original Article: Update on Office-Based Strategies for the Management of Obesity

Issue Date: September 1, 2016

See additional reader comments at:

To the Editor: Drs. Erlandson and colleagues provided a useful overview about obesity management. However, the article did not discuss the lack of patient-oriented evidence for medications approved by the U.S. Food and Drug Administration (FDA) for the management of obesity. These medications can help with weight loss, but none have been shown to reduce cardiovascular morbidity or mortality.1 Although these new treatments have been FDA approved, that does not mean that they are definitively safe, cheaper, or more effective than older options. Helping patients with lifestyle modifications and improving social determinants of health is more effective to achieve and maintain weight loss and positive long-term health outcomes.

Email letter submissions to Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading

More in AFP

More in PubMed

Copyright © 2018 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.